Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LINDEVEJ FYSIOTERAPI- OG SUNDHEDSKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   12.2% 9.9% 12.8% 12.2% 13.2% 8.0% 16.1% 15.9%   Credit score (0-100)   21 26 18 18 17 30 11 12   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   964 672 894 1,056 1,184 798 0.0 0.0   EBITDA   80.3 -13.9 115 85.9 134 -33.8 0.0 0.0   EBIT   34.7 -42.9 95.1 58.6 116 -33.8 0.0 0.0   Pre-tax profit (PTP)   6.8 -63.5 79.7 44.2 100.1 -49.5 0.0 0.0   Net earnings   4.8 -49.8 61.6 34.1 77.0 -39.8 0.0 0.0   Pre-tax profit without non-rec. items   6.8 -63.5 79.7 44.2 100 -49.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -146 -195 -134 -99.7 -22.7 -62.5 -142 -142   Interest-bearing liabilities   333 326 262 257 196 253 142 142   Balance sheet total (assets)   381 364 410 329 332 313 0.0 0.0   Net Debt   324 311 238 242 194 243 142 142     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   964 672 894 1,056 1,184 798 0.0 0.0   Gross profit growth   -10.4% -30.3% 33.1% 18.1% 12.2% -32.6% -100.0% 0.0%   Employees   0 0 0 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   381 364 410 329 332 313 0 0   Balance sheet change%   -7.5% -4.6% 12.7% -19.9% 0.9% -5.7% -100.0% 0.0%   Added value   80.3 -13.9 114.5 85.9 143.2 -33.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -80 -52 -39 -47 -29 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 2.0 3.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.6% -6.4% 10.6% 5.6% 9.8% -4.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.4% -7.9% 17.2% 12.1% 29.6% -9.3% 0.0% 0.0%   ROI %   10.5% -13.0% 32.3% 22.6% 51.1% -15.0% 0.0% 0.0%   ROE %   1.2% -13.4% 15.9% 9.2% 23.3% -12.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -27.6% -34.9% -24.6% -23.3% -6.4% -16.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   403.5% -2,236.4% 207.6% 281.2% 144.4% -720.5% 0.0% 0.0%   Gearing %   -229.0% -166.8% -196.1% -258.3% -866.0% -405.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.4% 6.2% 5.2% 5.6% 7.0% 7.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.6 0.6 0.7 0.7 0.9 0.8 0.0 0.0   Current Ratio   0.6 0.6 0.7 0.7 0.9 0.8 0.0 0.0   Cash and cash equivalent   9.1 14.6 24.5 15.7 2.5 9.7 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -200.5 -244.9 -164.0 -110.7 -22.7 -62.5 -71.2 -71.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 43 72 -11 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 43 67 -11 0 0   EBIT / employee   0 0 0 29 58 -11 0 0   Net earnings / employee   0 0 0 17 38 -13 0 0